Home » Teva Wins FDA Tentative Approval for Generic Breast Cancer Drug
Teva Wins FDA Tentative Approval for Generic Breast Cancer Drug
Teva Pharmaceutical Industries has reported that the FDA has granted
tentative approval for the company’s abbreviated new drug application to
market its generic version of Novartis’s breast cancer treatment Femara tablets, 2.5mg.
TradingMarkets
TradingMarkets
Upcoming Events
-
07May
-
14May
-
30May